ArticleScientific reports2024

Prognosis and influencing factors of ER-positive, HER2-low breast cancer patients with residual disease after neoadjuvant chemotherapy: a retrospective study.

Lingfeng Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.